Author: J. Triebel

Communications in Prolactin Research: Sequencing Report of a Monoclonal Vasoinhibin Antibody

Posted on June 9, 2025 by J. Triebel

https://www.communications-in-prolactin-research.com/article/id/3

Anti-vasoinhibin monoclonal antibodies (Vi-Mab)

Posted on June 4, 2025June 5, 2025 by J. Triebel

Anti-vasoinhibin monoclonal antibodies (Vi-Mab) are commercially available at Davids Biotechnologie GmbH (Regensburg, Germany). https://davids-science.de/en/p/vasoinhibin-monoclonal-antibody-mouse-monoclonal-or-vi-mab

Communications in Prolactin Research (CPR)

Posted on June 4, 2025June 5, 2025 by J. Triebel

Communications in Prolactin Research (CPR) is a new, international, peer-reviewed, open access biomedical specialty journal devoted to publishing articles and scientific communications concerning the hormone prolactin. The following article types

Meta